• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2010 - Product Image

Puerto Rico Pharmaceuticals and Healthcare Report Q2 2010

  • Published: March 2010
  • Region: Puerto Rico
  • 69 Pages
  • Business Monitor International


  • Abbott Laboratories
  • Eli Lilly
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

Puerto Rico Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Puerto Rico's pharmaceuticals and healthcare industry.

In BMI’s updated Q210 Business Environment Rating (BER) matrix for the 10 major pharmaceutical markets in the Americas, Puerto Rico – the US-affiliated territory – remains placed third, below the US and Canada. While the territory has a well-developed regulatory environment and extremely close political relations with the US, its domestic market potential is limited by small population numbers, as well as by the considerably higher longer-term potential of emerging, rival manufacturing locations in Latin America or Asia. Therefore, Puerto Rico is likely to slip further down the matrix over the coming years, as Brazil and Mexico, for example, gain in attractiveness to foreign players looking to expand. Following the closures of a number of local plants operated by US multinationals over the past few years, Canadian contract manufacturer Patheon reported in December READ MORE >

Executive Summary

SWOT Analysis
Puerto Rico Pharmaceuticals And Healthcare Industry SWOT

Pharmaceutical Business Environment Ratings
Table: Americas – Regional Pharmaceutical Business Environment Ratings, Q210
Limits to Potential Returns
Risks to Realisation of Returns

Puerto Rico – Market Summary

Regulatory Regime
Pricing and Reimbursement Issues
Tax Incentives
Table: Puerto Rico – Incentives, Benefits And Discounts For Pharmaceutical Manufacturers
Trade Accords

Industry Developments
Healthcare Sector
Healthcare Financing
Healthcare Reforms
Pharmaceutical Wholesale and Distribution
Recent Pharmaceutical Wholesale and Distribution Activities
Research and Development
Clinical Trials
Medical Devices
Recent Developments in Medical Devices Market

Industry Forecast Scenario
Overall Market Forecast
Key Growth Factors – Industry
Key Growth Factors – Macroeconomic
Table: Puerto Rico: Historical Data And Forecasts
Prescription Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Drug Market Forecast
Medical Device Market Forecast
Pharmaceutical Trade Forecast
Other Healthcare Data Forecasts
Key Risks to BMI’s Forecast Scenario

Competitive Landscape
Pharmaceutical Industry
Table: Puerto Rico: Multinational Downscaling
Pharmaceutical Production
Plant Closures
Recent Company Developments

Company Monitor
Merck & Co
Abbott Laboratories
Eli Lilly

Country Snapshot: Puerto Rico Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education and Healthcare
Table: Vital Statistics, 2005-2030
Section 3: Labour Market and Spending Power
Table: Employment Indicators, 1999-2004
Table: Average Annual Manufacturing Wages, 2000-2012

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Table: Weighting Of Components

Forecast Tables

- Pfizer
- GlaxoSmithKline
- Merck & Co
- Abbott Laboratories
- Novartis
- Sanofi-Aventis
- Eli Lilly

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos